Intensive Telehealth Program Improves A1c In Rural Patients with Type 2 DiabetesJune 15th 2020
ADA 2020. Improvement in glycemic control among US veterans was seen across 5 study sites and was sustained at 18 months after study initiation, says study reported at the ADA 80th Virtual Scientific Sessions.
ADA2020: SGLT-2 Inhibitor Delays Insulin Initiation, Intensification in T2D with CVDJune 14th 2020
ADA2020: Empagliflozin significantly, durably delays need for insulin and for large dose increases, in patients with type 2 diabetes and cardiovascular disease, finds study presented at ADA 80th Scientific Sessions.
ADA: Next Generation “Artificial Pancreas” Improves Glycemic Control, A1c in T1DJune 13th 2020
ADA 2020: A new automatic insulin delivery system improves glycemic control in young people with type 1 diabetes, according to research presented at the American Diabetes Association Virtual Scientific Sessions.
A Pro-Con Debate on How to Care for Patients With Interstitial Lung DiseaseMay 21st 2019
DALLAS--Which patients are candidates for antifibrotic therapy? Is extracorporeal membrane oxygenation appropriate for all ILD patients? The topics were hotly debated on Monday at the American Thoracic Society meeting.